STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATHA
  4. [Form 4] LeonaBio, Inc. Insider Trading Activity

LeonaBio (LONA) director receives 56,000 stock options at $9.63 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LeonaBio, Inc. director Natalie C. Holles received a grant of stock options covering 56,000 shares of common stock. The options have an exercise price of $9.63 per share and expire on May 4, 2036. The award vests in equal monthly installments over 36 months, contingent on her continued service as a Service Provider under the company’s 2026 Equity Incentive Plan. Following this grant, she holds 56,000 stock options directly.

Positive

  • None.

Negative

  • None.
Insider Holles Natalie C.
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 56,000 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 56,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Option Grant Size 56,000 options Stock Option (Right to Buy) granted to director
Exercise Price $9.63 per share Conversion/exercise price of stock options
Expiration Date May 4, 2036 Option expiration for the 56,000-share grant
Underlying Shares 56,000 shares Common Stock underlying the stock options
Post-Grant Holdings 56,000 options Total options beneficially owned after transaction
Vesting Schedule 36 monthly installments Monthly vesting over 36 months from grant date
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "9.6300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
2026 Equity Incentive Plan financial
"as defined in the Issuer's 2026 Equity Incentive Plan"
Service Provider financial
"subject to the optionee continuing to be a Service Provider"
vesting financial
"scheduled to vest monthly over a term of 36 months"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Holles Natalie C.
(Last)(First)(Middle)
C/O LEONABIO, INC.
18706 NORTH CREEK PARKWAY, SUITE 104
(Street)
BOTHELL WASHINGTON 98011
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LeonaBio, Inc. [ LONA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$9.6305/05/2026A56,000 (1)05/04/2036Common Stock56,000$056,000D
Explanation of Responses:
1. The shares subject to the option are scheduled to vest monthly over a term of 36 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates.
/s/ Mark Worthington, Attorney in fact for Natalie C. Holles05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Natalie C. Holles report in this Form 4 for LONA?

Natalie C. Holles reported receiving a grant of stock options for 56,000 shares of LeonaBio common stock. The options were awarded as compensation and give her the right to buy shares at a fixed exercise price of $9.63 per share.

What are the key terms of Natalie Holles’s 56,000 LeonaBio stock options?

The 56,000 stock options have an exercise price of $9.63 per share and expire on May 4, 2036. They represent a right, not an obligation, to purchase LeonaBio common stock at that fixed price in the future.

How do the LeonaBio options granted to Natalie Holles vest over time?

The options are scheduled to vest monthly over 36 months from the grant date. Each monthly anniversary triggers a portion of the 56,000 options to vest, provided she continues as a Service Provider under LeonaBio’s 2026 Equity Incentive Plan.

How many LeonaBio options does Natalie Holles hold after this transaction?

After this grant, Natalie Holles holds 56,000 LeonaBio stock options directly. This figure reflects the total options reported as beneficially owned following the transaction, all tied to this single award.

Is Natalie Holles’s Form 4 transaction a purchase or a compensation grant in LONA?

The Form 4 reflects a compensation grant, not an open-market purchase. The transaction code "A" denotes a grant or award of options, giving her rights to buy shares at $9.63, rather than buying shares on the market.